These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 8593275
1. Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: drug carriers with an intrinsic anti-HIV activity. Kamps JA, Swart PJ, Morselt HW, Pauwels R, De Béthune MP, De Clercq E, Meijer DK, Scherphof GL. Biochim Biophys Acta; 1996 Jan 31; 1278(2):183-90. PubMed ID: 8593275 [Abstract] [Full Text] [Related]
2. Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells. Kamps JA, Morselt HW, Swart PJ, Meijer DK, Scherphof GL. Proc Natl Acad Sci U S A; 1997 Oct 14; 94(21):11681-5. PubMed ID: 9326670 [Abstract] [Full Text] [Related]
3. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity. Jansen RW, Schols D, Pauwels R, De Clercq E, Meijer DK. Mol Pharmacol; 1993 Nov 14; 44(5):1003-7. PubMed ID: 7902528 [Abstract] [Full Text] [Related]
4. The influence of charge clustering on the anti-HIV-1 activity and in vivo distribution of negatively charged albumins. Beljaars L, Floris R, Berkhout B, Smit C, Meijer DK, Molema G. Biochem Pharmacol; 2002 May 01; 63(9):1663-73. PubMed ID: 12007569 [Abstract] [Full Text] [Related]
5. Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA. Swart PJ, Beljaars E, Smit C, Pasma A, Schuitemaker H, Meijer DK. J Drug Target; 1996 May 01; 4(2):109-16. PubMed ID: 8894971 [Abstract] [Full Text] [Related]
6. Massive and selective delivery of lipid-coated cationic lipoplexes of oligonucleotides targeted in vivo to hepatic endothelial cells. Bartsch M, Weeke-Klimp AH, Meijer DK, Scherphof GL, Kamps JA. Pharm Res; 2002 May 01; 19(5):676-80. PubMed ID: 12069172 [Abstract] [Full Text] [Related]
7. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4. Cabrera C, Witvrouw M, Gutiérrez A, Clotet B, Kuipers ME, Swart PJ, Meijer DK, Desmyter J, De Clercq E, Esté JA. AIDS Res Hum Retroviruses; 1999 Nov 20; 15(17):1535-43. PubMed ID: 10580404 [Abstract] [Full Text] [Related]
8. Anti-HIV-1 activity of combinations and covalent conjugates of negatively charged human serum albumins (NCAs) and AZT. Kuipers ME, Swart PJ, Witvrouw M, Esté JA, Reymen D, De Clercq E, Meijer DK. J Drug Target; 1999 Nov 20; 6(5):323-35. PubMed ID: 10342381 [Abstract] [Full Text] [Related]
9. Pharmacokinetics and anti-HIV-1 efficacy of negatively charged human serum albumins in mice. Kuipers ME, Swart PJ, Schutten M, Smit C, Proost JH, Osterhaus AD, Meijer DK. Antiviral Res; 1997 Jan 20; 33(2):99-108. PubMed ID: 9021051 [Abstract] [Full Text] [Related]
10. The metabolic fate of the Anti-HIV active drug carrier succinylated human serum albumin after intravenous administration in rats. Swart PJ, Kuipers ME, Smit C, Beljaars L, Ter Wiel J, Meijer DK. J Drug Target; 2001 Apr 20; 9(2):95-109. PubMed ID: 11697111 [Abstract] [Full Text] [Related]
11. Novel long-circulating liposomes containing peptide library-lipid conjugates: synthesis and in vivo behavior. Riché EL, Erickson BW, Cho MJ. J Drug Target; 2004 Jul 20; 12(6):355-61. PubMed ID: 15545085 [Abstract] [Full Text] [Related]
12. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L. Biochim Biophys Acta; 1991 Feb 25; 1062(2):142-8. PubMed ID: 2004104 [Abstract] [Full Text] [Related]
14. Potent inhibition of replication of primary HIV type 1 isolates in peripheral blood lymphocytes by negatively charged human serum albumins. Groenink M, Swart PJ, Broersen S, Kuipers M, Meijer DK, Schuitemaker H. AIDS Res Hum Retroviruses; 1997 Jan 20; 13(2):179-85. PubMed ID: 9007203 [Abstract] [Full Text] [Related]
15. Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. Parr MJ, Ansell SM, Choi LS, Cullis PR. Biochim Biophys Acta; 1994 Oct 12; 1195(1):21-30. PubMed ID: 7918562 [Abstract] [Full Text] [Related]
16. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Dos Santos N, Allen C, Doppen AM, Anantha M, Cox KA, Gallagher RC, Karlsson G, Edwards K, Kenner G, Samuels L, Webb MS, Bally MB. Biochim Biophys Acta; 2007 Jun 12; 1768(6):1367-77. PubMed ID: 17400180 [Abstract] [Full Text] [Related]
17. Targeting of antiviral drugs to T4-lymphocytes. Anti-HIV activity of neoglycoprotein-AZTMP conjugates in vitro. Molema G, Jansen RW, Pauwels R, de Clercq E, Meijer DK. Biochem Pharmacol; 1990 Dec 15; 40(12):2603-10. PubMed ID: 1979734 [Abstract] [Full Text] [Related]
18. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Gabizon A, Horowitz AT, Goren D, Tzemach D, Mandelbaum-Shavit F, Qazen MM, Zalipsky S. Bioconjug Chem; 1999 Dec 15; 10(2):289-98. PubMed ID: 10077479 [Abstract] [Full Text] [Related]
19. Pharmacokinetic analysis and cellular distribution of the anti-HIV compound succinylated human serum albumin (Suc-HSA) in vivo and in the isolated perfused rat liver. Jansen RW, Olinga P, Harms G, Meijer DK. Pharm Res; 1993 Nov 15; 10(11):1611-4. PubMed ID: 8290473 [Abstract] [Full Text] [Related]
20. Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes. Li WM, Xue L, Mayer LD, Bally MB. Biochim Biophys Acta; 2001 Aug 06; 1513(2):193-206. PubMed ID: 11470091 [Abstract] [Full Text] [Related] Page: [Next] [New Search]